Use of Newer Disease-Modifying Therapies in Pediatric Multiple Sclerosis in the USNeurol 91:e1778-e1787, Krysko, K.M.,et al, 2018
Newer Agents in the Treatment of Multiple SclerosisNeurologist 19:104-117, Pawate, S. & Bagnato F., 2015